MICHAEL ALAN LEVINE

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology PHILADELPHIA, PA NPI 1811033962

General Payments — all program years on this page

$117,795.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $28,272.50 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $28,272.5010

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,828.418
2019 $35,574.8931
2020 $4,115.811
2021 $7,570.004
2022 $10,730.005
2023 $25,703.7710
2024 $28,272.5010

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093917665 Alexion Pharmaceuticals, Inc. $2,100.00 12/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093979359 Alexion Pharmaceuticals, Inc. $1,400.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093983302 Alexion Pharmaceuticals, Inc. $1,400.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093986611 Alexion Pharmaceuticals, Inc. $2,800.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1100675808 Day One Biopharmaceuticals $3,500.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323651 Mirum Pharmaceuticals, Inc. $700.00 10/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131807065 PFIZER INC. $500.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1134610269 CSL Behring $4,200.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137618857 Takeda Pharmaceuticals U.S.A., Inc. $1,522.50 01/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141323938 Marinus Pharmaceuticals, Inc. $10,150.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.